Variant report
Variant | nsv8198 |
---|---|
Chromosome Location | chr7:109421605-109423480 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538518815 | chr7:109421634-109421635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs145628597 | chr7:109421661-109421662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10282619 | chr7:109421700-109421701 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs186168602 | chr7:109421759-109421760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7797225 | chr7:109421760-109421761 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs557253725 | chr7:109421795-109421796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs940503 | chr7:109421839-109421840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs191614186 | chr7:109421881-109421882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs559621384 | chr7:109421892-109421893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs11349080 | chr7:109421899-109421900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs398086060 | chr7:109421904-109421905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182857065 | chr7:109421909-109421910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541834680 | chr7:109421919-109421920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs536064162 | chr7:109421946-109421947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186011636 | chr7:109421963-109421964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141903127 | chr7:109421972-109421973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564116327 | chr7:109422020-109422021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs7797714 | chr7:109422023-109422024 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs546870704 | chr7:109422041-109422042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539969410 | chr7:109422086-109422087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566795564 | chr7:109422105-109422106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535406978 | chr7:109422112-109422113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548984575 | chr7:109422128-109422129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7797470 | chr7:109422136-109422137 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs537543019 | chr7:109422158-109422159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557876650 | chr7:109422184-109422185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577327402 | chr7:109422204-109422205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190815287 | chr7:109422242-109422243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs183151862 | chr7:109422258-109422259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs115884845 | chr7:109422309-109422310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7784542 | chr7:109422362-109422363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189123532 | chr7:109422395-109422396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561861598 | chr7:109422473-109422474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs376951538 | chr7:109422475-109422476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs575634420 | chr7:109422484-109422485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543701255 | chr7:109422505-109422506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs561840463 | chr7:109422510-109422511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs3107925 | chr7:109422521-109422522 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs564607257 | chr7:109422560-109422561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150209921 | chr7:109422612-109422613 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573463838 | chr7:109422613-109422614 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs192140174 | chr7:109422659-109422660 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs368152536 | chr7:109422702-109422703 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs62478945 | chr7:109422703-109422704 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs75304570 | chr7:109422735-109422736 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs373765764 | chr7:109422757-109422758 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565462930 | chr7:109422763-109422764 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568753283 | chr7:109422771-109422772 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531348878 | chr7:109422780-109422781 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs531266781 | chr7:109422781-109422782 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 16397240 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Autism | 19401682 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:109420600-109422600 | Enhancers | Dnd41 | blood |
2 | chr7:109422600-109422800 | Flanking Active TSS | Dnd41 | blood |
3 | chr7:109422800-109423000 | Enhancers | Dnd41 | blood |
4 | chr7:109423000-109423200 | Flanking Active TSS | Dnd41 | blood |
5 | chr7:109423200-109425600 | Enhancers | Dnd41 | blood |